Zydus Cadila launches Ramelteon tablets in US to treat insomnia

In a BSE filing, Zydus Cadila announced the "launch of Ramelteon tablets, 8 mg upon receiving the final approval from the USFDA. Ramelteon is a sedative, also called a hypnotic".

New Delhi: Zydus Cadila on Wednesday launched Ramelteon tablets, used to treat insomnia, in the US market.

In a BSE filing, Zydus Cadila announced the "launch of Ramelteon tablets, 8 mg upon receiving the final approval from the USFDA. Ramelteon is a sedative, also called a hypnotic".

Ramelteon is used to treat insomnia that is associated with having trouble falling asleep.

Read Also: Zydus Cadila arm gets USFDA nod for generic version of Adderall XR capsules in US

Zydus Cadila said the drug will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.

The Gujarat-based group has more than 270 USFDA approvals and has filed over 360 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04.

Read Also: Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila